These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11267473)

  • 61. [Analysis of rejection after simultaneous pancreas-kidney transplantation].
    Yang L; Liu YF; Liu SR; Liang J; Cui H; Meng YM; Wu G; Li GC
    Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(15):926-8. PubMed ID: 15363255
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Rejection after simultaneous pancreas-kidney transplantation.
    Arbogast H; Malaise J; Illner WD; Tarabichi A; Dieterle C; Landgraf R; Land W;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants.
    Kee TY; Chapman JR; O'Connell PJ; Fung CL; Allen RD; Kable K; Vitalone MJ; Nankivell BJ
    Transplantation; 2006 Jul; 82(1):36-42. PubMed ID: 16861939
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Experience with sirolimus for calcineurin minimization/elimination in pancreas-after-kidney transplantation.
    Gautam A; Morrissey PE; Gohh R; Yango A; Monaco AP
    Transplant Proc; 2005 Oct; 37(8):3542-3. PubMed ID: 16298654
    [TBL] [Abstract][Full Text] [Related]  

  • 66. FK 506 in simultaneous pancreas/kidney transplantation: the University of Miami experience.
    Demirbas A; Ciancio G; Burke G; Roth D; Karatzas T; Tzakis A; Miller J
    Transplant Proc; 1997 Nov; 29(7):2903. PubMed ID: 9365608
    [No Abstract]   [Full Text] [Related]  

  • 67. FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group.
    Miller J; Pirsch JD; Deierhoi M; Vincenti F; Filo RS
    Transplant Proc; 1997; 29(1-2):304-5. PubMed ID: 9123008
    [No Abstract]   [Full Text] [Related]  

  • 68. Mycophenolate mofetil improves long-term graft survival following renal transplantation in patients experiencing delayed graft function. International Mycophenolate Mofetil Renal Study Groups.
    Cho S; Hodge E; Navarro M
    Transplant Proc; 1999; 31(1-2):322-3. PubMed ID: 10083126
    [No Abstract]   [Full Text] [Related]  

  • 69. Use of intravenous tacrolimus to reverse vascular rejection in kidney and simultaneous kidney-pancreas transplantation.
    Ciancio G; Burke G; Viciana A; Ruiz P; Roth D; Khan TF; Montane B; Strauss J; Miller J
    Transplant Proc; 1998 Jun; 30(4):1536-7. PubMed ID: 9636624
    [No Abstract]   [Full Text] [Related]  

  • 70. Tacrolimus-based vs cyclosporine-based immunotherapy in combined kidney-pancreas transplantation.
    Ketel BL; Turton-Weeks S; Reed K; Barone GW
    Transplant Proc; 1996 Apr; 28(2):899. PubMed ID: 8623453
    [No Abstract]   [Full Text] [Related]  

  • 71. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
    Bruce DS; Newell KA; Woodle ES; Millis JM; Piper JB; Huss E; Thistlethwaite JR
    Transplant Proc; 1996 Aug; 28(4):2136-7. PubMed ID: 8769180
    [No Abstract]   [Full Text] [Related]  

  • 72. ATGAM versus OKT3 induction therapy in cadaveric kidney transplantation: patient and graft survival, CD3 subset, infection, and cost analysis.
    Kumar MS; Cahill K; Kumar AM; Panigrahi D; Seirka D; Singleton R; al-Abdullah IH; Laskow DA
    Transplant Proc; 1998 Jun; 30(4):1351-2. PubMed ID: 9636549
    [No Abstract]   [Full Text] [Related]  

  • 73. Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal.
    Cronin DC; Bruce DS; Newell KA; Josephson MA; Millis JM; Piper JB; Ruebe M; Kirby M; Thistlethwaite JR; Woodle ES
    Transplant Proc; 1997; 29(1-2):307. PubMed ID: 9123010
    [No Abstract]   [Full Text] [Related]  

  • 74. Can acute rejection be prevented in SPK transplantation?
    Burke G; Ciancio G; Figueiro J; Olson L; Gomez C; Rosen A; Suzart K; Miller J
    Transplant Proc; 2002 Aug; 34(5):1913-4. PubMed ID: 12176626
    [No Abstract]   [Full Text] [Related]  

  • 75. Mycophenolate mofetil for prevention of acute rejection.
    Moore R; Griffin P; Darby C; Jurewicz A; Lord R
    Lancet; 1995 Jul; 346(8969):253. PubMed ID: 7616827
    [No Abstract]   [Full Text] [Related]  

  • 76. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine.
    Stegall MD; Simon M; Wachs ME; Chan L; Nolan C; Kam I
    Transplantation; 1997 Dec; 64(12):1695-700. PubMed ID: 9422404
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Indications for mycofenolate mofetil therapy after liver transplantation.
    Platz KP; Mueller AR; Neuhaus P
    Transplant Proc; 1997 Nov; 29(7):2880-1. PubMed ID: 9365601
    [No Abstract]   [Full Text] [Related]  

  • 78. Tacrolimus for steroid- and OKT3-resistant rejection in kidney recipients.
    Kliem V; Petersen R; Ehlerding G; Schaumann D; Eisenberger U; Koch KM; Pichlmayr R; Brunkhorst R
    Transplant Proc; 1998 Jun; 30(4):1251-3. PubMed ID: 9636509
    [No Abstract]   [Full Text] [Related]  

  • 79. Acute rejection and the therapeutic choice of drug.
    Ichikawa Y; Nojima M; Kyo M; Yazawa K; Hanafusa T; Ebisui C; Tsubakihara Y; Fukunishi T; Nagano S
    Transplant Proc; 2000 Nov; 32(7):1759-60. PubMed ID: 11119923
    [No Abstract]   [Full Text] [Related]  

  • 80. Pancreas transplantation with ATG vs OKT3.
    Rosenberg L
    Transplant Proc; 1997 Nov; 29(7A):35S-36S. PubMed ID: 9366927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.